Regression grading of colorectal carcinoma after preoperative radiochemotherapy. An inventory;Regressionsgrading des präoperativ-radiochemotherapierten rektumkarzinoms: Eine bestandsaufnahme

Pathologe

Volumn 24, Issue 1, 2003, Pages 61-65

  Wittekind, C ^a   Tannapfel, A ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Pathology; Prognostic factor; Radiochemotherapy; Rectal carcinoma; Staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; COLORECTAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PATHOLOGIST; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY; REVIEW; STANDARDIZATION; TUMOR REGRESSION; COLON TUMOR; COLORECTAL TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RECTUM TUMOR; TREATMENT OUTCOME;

COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; PREOPERATIVE CARE; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 0037799161     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-002-0602-9     Document Type: Review

References (33)

1. Ancona E, Ruol A, Merigliano S et al. (2001) Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 91:2165-2174
2. Becker K, Fink U, Siewert JR, Höfler H (1996) Morphologische Veränderungen nach präoperativer Chemotherapie lokal fortgeschrittener Magenkarzinome. Verh Dtsch Ges Pathol 80:400
3. Becker K, Mueller J, Fink U et al. (1997) The interpretation of pathologic changes in the resection specimen following multimodal therapy forgastric adenocarcinoma. In: Siewert JR, Roder JD (eds) Progress in gastric cancer research. Monduzzi, Bologna, pp 1275-1279
4. Blenkinsop WK, Stewart-Brown S, Blesovsky L, Kearney G, Fielding JP (1981) Histopathology reporting in large bowel cancer. J Clin Pathol 34:598-613
5. Bonzourene H, Bosman FT, Seelentag W, Matter M, Coucke P (2002) Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94:1121-1139
6. Böttcher K, Stein HJ, Becker K et al. (2000) Magenkarzinom. In: Roder JD, Stein HJ, Fink U (Hrsg) Therapie gastrointestinaler Tumoren. Prinzipien der chirurgischen Klinik und Poliklinik der Technischen Universität München. Springer, Berlin Heidelberg New York, S 217-241
7. Bozetti F, Andreola S, Rosetti C et al. (1996) Preoperative radiotherapy for resectable cancer of the middle-distal rectum: its effect on the primary lesion is determined by endorectal ultrasound using flexible echo colonoscope. Int J Colorect Dis 11:283-286
8. Bull AD, Biffin AHB, Meila J et al. (1997) Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 50:138-142
9. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorect Dis 12:19-23
10. Gehan E, Schneiderman SM (1990) Historical and methodological developments in clinical trials at the National Cancer Institute. Stat Med 9:871-880
11. Gospodarowicz M, Hermanek P, Henson DE (1995) Introduction to prognostic factors in cancer. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognostic factors in cancer. Springer, Berlin Heidelberg New York Tokyo, pp 1-11
12. Hermanek P (1997) Staging systems: a review. In: Soreide O, Norstein J (eds) Rectal cancer surgery. Optimisation - Standardisation - Documentation. Springer, Berlin Heidelberg New York Tokyo, pp 45-62
13. Hermanek P, Sobin LH (199S) Colorectal carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognos-tic factors in cancer. Springer, Berlin Heidelberg New York Tokyo, pp 64-79
14. Japanese Research Society for Gastric Cancer, Nishi M, Omori Y, Miwa K (eds) (1995) Japanese classification of gastric carcinoma, 1st English edn. Kanehara Shuppan, Tokyo
15. Japanese Society for Cancer of the Colon and Rectum (JSCCR) (1997) Japanese classification of colorectal carcinoma, 1st English edn. Kanehara & Co, Tokyo
16. Junginger T, Hermanek P, Klimpfinger M (2002) Klassifikation maligner Tumoren des Gastrointestinaltraktes I. Springer, Berlin Heidelberg New York
17. Junker K, Langner K, Klinke F, Bosse U, Thomas M (2001) Grading of tumor regression in non-small cell lung cancer: morphology and prognosis. Chest 120:1584-1591
18. Mandard AM, Dalibard F, Mandard JC et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73:2680-2686
19. Miller AB, Hogestraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214
20. Quirke P (1998) The pathologist, the surgeon and colorectal cancer-get it right because it matters. In: Kirkham N, Lemoine NR (eds) Progress in pathology, vol 4. Churchill Livingstone, Edinburgh London New York Philadelphia San Francisco Sydney Toronto, pp 201-213
21. Roder JD, Stein H, Siewert JR (1995) Oesophageal carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognostic factors in cancer. Springer, Berlin Heidelberg New York, pp 37-46
22. Schneider PM, Zirbes TK, Metzger R et al. (1999) Histomorphologisches Regressionsgrading und Apoptose-Index als objektive Responseparameter beim neoadjuvant chemotherapierten Adenocarcinom des Magens und ösophagogastralen Überganges. Langenbecks Arch Chir [Suppl 1] (Forumband):17-21
23. Sinn HP, Hermanek P, Wagner G, Wittekind C (2003) Organspezifische Tumordokumentation, 3.Aufl./Internetfassung (OTD-3.Internet). Deutsche Krebsgesellschaft, Frankfurt/Main. http://www.krebsgesell-schaft.de
24. Stein HJ, Feith M (2001) Prognostic factors in cancer. In: Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind C (eds) Prognostic factors in cancer, 2nd edn.Wiley, New York, pp 237-249
25. Tannapfel A, Köckerling F, Katalinic A, Wittekind C (1995) Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum 38:651-654
26. UICC (1993) TNM Supplement 1993. A commentary on uniform use. Hermanek P, Henson DE, Hutter RVP, Sobin LH (eds) Springer, Berlin Heidelberg New York
27. UICC (1997) TNM Classification of malignant tumours, 5th edn. Sobin LH, Wittekind C (eds) Wiley-Liss, New York
28. UICC (2001) TNM Supplement, 2nd edn. A commentary on uniform use. Wittekind C, Henson DE, Hutter RVP, Sobin LH (eds), Wiley, New York
29. UICC (2002) TNM classification of malignant tumours, 6th edn. Sobin LH, Wittekind C (eds) Wiley-Liss, New York
30. Werner M, Höfler H (2000) Pathologie. In: Roder JD, Stein HJ, Fink U (Hrsg) Therapie gastrointestinaler Tumoren. Prinzipien der Chirurgsichen Klinik und Poliklinik der Technischen Universität München. Springer, Berlin Heidelberg New York, S 45-53
31. WHO Handbook for reporting results of cancer treatment (1979) Geneva (Switzerland). World Health Organization Offset Publication No. 48
32. Wittekind C (1993) Bedeutung von Tumorwachstum und -ausbreitung für die chirurgische Radikalität. Zentralbl Chir 118:500-507
33. Zubrod CG, Schneiderman SM, Frei E et al. (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and thio phosphamide. J Chron Dis 11:7-33